• International Journal of Reliability and Applications
• /
• 제4권2호
• /
• pp.79-95
• /
• 2003

Manufacturers collect and analyze field reliability data to enhance the quality and reliability of their products and to improve customer satisfaction. To reduce the data collecting and maintenance costs, the amount of data maintained for evaluating product quality and reliability should be minimized. With this in mind, some industrial companies assemble warranty databases by gathering data from different sources for a particular time period. This “marginal count failure data” does not provide (i) the number of failures by when the product entered service, (ii) the number of failures by product age, or (iii) information about the effects of the operating season or environment. This article describes a method for estimating age-based claim rates from marginal count failure data. It uses covariates to identify variations in claims relative to variables such as manufacturing characteristics, time of manufacture, operating season or environment. A Poisson model is presented, and the method is illustrated using warranty claims data for two electrical products.

• 보건행정학회지
• /
• 제25권3호
• /
• pp.197-206
• /
• 2015

Background: The purpose of this study was to propose a method for developing a measure of hospital-wide all-cause risk-standardized readmissions using administrative claims data in Korea and to discuss further considerations in the refinement and implementation of the readmission measure. Methods: By adapting the methodology of the United States Center for Medicare & Medicaid Services for creating a 30-day readmission measure, we developed a 6-step approach for generating a comparable measure using Korean datasets. Using the 2010 Korean National Health Insurance (NHI) claims data as the development dataset, hierarchical regression models were fitted to calculate a hospital-wide all-cause risk-standardized readmission measure. Six regression models were fitted to calculate the readmission rates of six clinical condition groups, respectively and a single, weighted, overall readmission rate was calculated from the readmission rates of these subgroups. Lastly, the case mix differences among hospitals were risk-adjusted using patient-level comorbidity variables. The model was validated using the 2009 NHI claims data as the validation dataset. Results: The unadjusted, hospital-wide all-cause readmission rate was 13.37%, and the adjusted risk-standardized rate was 10.90%, varying by hospital type. The highest risk-standardized readmission rate was in hospitals (11.43%), followed by general hospitals (9.40%) and tertiary hospitals (7.04%). Conclusion: The newly developed, hospital-wide all-cause readmission measure can be used in quality and performance evaluations of hospitals in Korea. Needed are further methodological refinements of the readmission measures and also strategies to implement the measure as a hospital performance indicator.

• 한국임상약학회지
• /
• 제22권1호
• /
• pp.81-86
• /
• 2012

This study was aimed to examine the prescribing patterns of antivirals in outpatients with chronic hepatitis B (CHB), using National Health Insurance adjudicated claims data (total 1,426,065 claims) dated March 19, 2008 submitted from nationwide healthcare providers to Health Insurance Review and Assessment Service. From the data, there were 2,965 claims with CHB diagnosis (ICD-10 code B18.0 and B18.1), and 44.2% (1,311 claims) of the CHB related claims included antivirals such as lamivudine, clevudine, adefovir and entecavir. Lamivudine, adefovir, clevudine and entecavir shared 54.9%, 19.9%, 13.2% and 11.9%, respectively, among antiviral prescriptions. Adefovir and entecavir 1mg presumed as the 2nd line therapy for HBV resistant cases were shared 23.3% of overall antiviral prescriptions. There were statistically significant difference in prescription patterns according to age and institution type: Lamivudine usage was higher in younger (< 20 years old) and older age group (> 70 years old) than the others (p = 0.016), and adefovir and entecavir, which were relatively newer antivirals, had higher prescription rates in higher level of institutions such as tertiary hospitals than the others (p < 0.001). This study would be of help to make an appropriate drug therapy plan for patients with CHB.

• Journal of the Korean Data and Information Science Society
• /
• 제24권1호
• /
• pp.1-12
• /
• 2013

본 논문에서는 잉여금이 양의 추세모수를 갖는 확산과정을 따라 움직이고, 두 가지 유형의 보험청구가 있는 리스크 모형을 소개한다. 두 유형의 보험청구 금액은 서로 독립이고, 각각 지수분포를 따른다고 가정한다. 유형 I의 보험청구는 잦은 빈도로 발생하지만 청구 금액은 적고, 유형 II의 보험청구는 상대적으로 드물게 발생하지만 청구 금액이 많다고 가정한다. 적미분 방정식을 세워 잉여금이 없어지는 파산확률을 구하고, 각 유형에 의한 파산확률과 확산과정에 의해 자연적으로 파산이 이루어지는 확률을 함께 구한다. 또한 예제를 통해 두 유형의 보험청구와 확산과정이 전체 파산확률에 미치는 영향을 수치적으로 비교 분석한다.

• 사물인터넷융복합논문지
• /
• 제8권2호
• /
• pp.13-24
• /
• 2022

본 연구는 우리나라에서 매년 증가하고 있는 노인장기요양기관의 부당청구 맥락과 부당청구 예방을 위한 대책들이 어떠한지를 탐색하기 위해서 언론기사를 활용한 텍스트 마이닝 분석을 실시하였다. 기사는 뉴스 빅테이터 분석 시스템인 빅카인즈에서 수집하였고, 수집기간은 노인장기요양보험이 시행된 2008년 7월부터 2022년 2월 28일까지로 약 15년간이다. 이 기간 동안 '노인요양+부당청구', '장기요양+부당청구', 등의 키워드로 총 2,627개의 기사가 수집되었고, 이중 중복된 기사를 제외한 총 946개가 선정되었다. 본 연구의 텍스트마이닝 분석결과로 첫째, 모든 구간(2008.7.1-2022.2.28)에서 가장 높은 빈도로 언급된 상위 10위 키워드는 노인장기요양기관, 부당청구, 국민건강보험공단, 노인장기요양보험, 장기요양급여(비용), 노인요양시설, 보건복지부, 노인, 신고, 포상금(지급)의 순으로 나타났다. 둘째, N-gram 분석결과 장기요양급여(비용)과 부당청구, 부당청구와 노인장기요양기관, 허위와 부당청구, 신고와 포상금(지급), 노인장기요양기관과 신고 등의 순으로 나타났다. 셋째, TF-IDF 분석은 빈도분석의 결과와 유사하게 나타났지만, 신고, 포상금(지급), 증가 등은 순위가 상승하였다. 상기 분석결과를 바탕으로 노인장기요양기관 부당청구 예방을 위한 방향성을 제시하였다.

• Korean Journal of Acupuncture
• /
• 제34권3호
• /
• pp.126-135
• /
• 2017

Objectives : The purpose of this study was to describe the type of claimed adverse events related to Korean Medicine practices in South Korea. Methods : Claims with regard to the Korean Medicine practice submitted to the Korea Medical Dispute Mediation and Arbitration Agency from April 2012 to December 2016 were collected. We analyzed claims that explicitly reported the type of Korean medicine intervention and were deemed as being adverse events as defined by the Korea Good Clinical Practice. Claims that did not mention the Korean medicine practice explicitly or those related to the patient's dissatisfaction to the service rather than adverse health outcomes were excluded. Types, related interventions and the suspected severity of claimed adverse events were summarized. Results : Of 197 claims obtained, 140 claim cases were eligible and 144 claimed events were deemed as possible adverse events of the Korean medicine practice. Pain(16%), local infection/inflammation(12%) and neurological symptoms(11%) were the most frequently reported types of claimed adverse events. Thirty-nine claimed serious adverse events(SAE) were identified, including pneumothorax(28.2%) and death(17.9%). Conclusions : A wide range of claimed adverse events were identified. Routine monitoring of claims data may provide undetected safety information with regard to the Korean medicine practice. High risk of misclassification of the intervention and claimed adverse events due to insufficient information is the main caveat of this study.

• Journal of Preventive Medicine and Public Health
• /
• 제39권5호
• /
• pp.397-403
• /
• 2006

Objectives: We estimated the asthma-related health care utilization and costs in Korea from the insurer's and societal perspective. Methods: We extracted the insurance claims records from the Korea National Health Insurance claims database for determining the health care services provided to patients with asthma in 2003. Patients were defined as having asthma if they had ${\geq}$2 medical claims with diagnosis of asthma and they had been prescribed anti-asthma medicines, Annual claims records were aggeregated for each patient to produce patient-specific information on the total utilization and costs. The total asthma-related cost was the sum of the direct healthcare costs, the transportation costs for visits to health care providers and the patient's or caregivers' costs for the time spent on hospital or outpatient visits. Results: A total of 699,603people were identified as asthma patients, yielding an asthma prevalence of 1.47%. Each asthma patient had 7.56 outpatient visits, 0.01 ED visits and 0.02 admissions per year to treat asthma. The per-capita insurance-covered costs increased with age, from 128,276 Won for children aged 1 to 14 years to 270,729 Won for those aged 75 or older. The total cost in the nation varied from 121,865 million to 174,949 million Won depending on the perspectives. From a societal perspective, direct health care costs accounted for 84.9%, transportation costs for 15.1 % and time costs for 9.2% of the total costs. Conclusions: Hospitalizations and ED visits represented only a small portion of the asthma-related costs. Most of the societal burden was attributed to direct medical expenditures, with outpatient visits and medications emerging as the single largest cost components.

• 디지털융복합연구
• /
• 제11권10호
• /
• pp.593-608
• /
• 2013

상해상병으로 청구되는 건수가 증가함에 따라 조사 대상을 보다 정교하게 선정하여 상해요인 조사 대상을 줄이면서 환수율 및 환수금액을 올릴 수 있는 방안을 마련할 필요가 있다. 이를 위해서 2006~2011년까지의 상해요인 조사자료를 수집하여 의사결정나무 모형을 활용하여 지역가입자 상해상병 진료건에 대한 부당환수 조사대상 선정모형을 개발하였다. 최종 개발된 모형결과에 따르면, 조사대상 유형은 18개로 분류되었고, 이러한 분류결과는 실제 조사가 시행될 시, 모형을 적용하지 않았을 때 보다 최고 12.8배 높은 부당환수결정율을 나타낼 수 있을 것으로 분석되었다. 또한, 본 연구에서 개발된 조사 대상자 선정 모형을 실제 업무에 적용하기 위해서는 조사물량 대비 국민건강보험공단의 조사인력 및 운영 계획을 보다 면밀히 검토해야만 모형 적용의 효과성이 극대화 될 수 있을 것으로 판단된다.

• 디지털융복합연구
• /
• 제11권9호
• /
• pp.289-299
• /
• 2013

본 연구의 목적은 현재 질병관리본부에서 사용하고 있는 건강보험 청구자료 기반의 결핵환자 분류기준을 고도화하여 보다 효과적인 결핵환자감시체계의 토대를 제공하기 위해 수행되었다. 이를 위해 건강보험심사평가원의 2009년 1년간 결핵상병으로 청구된 81,199명 중 10%인 8,118명을 표본추출한 후 실제 결핵환자인지에 대해서 의무기록 조사를 실시하여 조사가 완료되고, 국민건강보험공단 건강보험청구 자료와 매칭이 완료된 7,132명을 최종 분석대상자로 하였다. 결핵환자분류를 위한 모형을 개발하여 평가한 결과 결핵과 관련된 임상전문가 의견과 통계적 분류 알고리즘이 종합적으로 고려된 의사결정나무모형이 가장 우수한 모형으로 평가되었다. 의사결정나무 모형에 따른 결핵분류모형의 주요 독립변수는 연령, 최초 청구시점의 결핵약제 종류수, 최초 청구시점의 이용 의료기관 유형, 최초 청구시점의 청구결핵검사 종류, 2008년 결핵약 투약일수, 최초 청구시점 결핵약제 투약일수, 최초 청구시점 결핵상병 종류로 나타났다. 이 모형의 향상도는 최고 11.8이였으며, 개발된 모형에서 분류된 1~5유형까지 적용하여 청구된 자료 중 결핵이 아님을 예측할 경우, 민감도는 90.6%, 양성예측도는 96.1%, 정분류율은 87.6%로 나타나, 현재 질병관리본부에서 사용하는 청구2회 이상, 약제 2제 이상 모형(민감도 82.6%, 양성예측도 95%, 정분류율 80%)보다 우수한 모형인 것으로 나타났다.

• Journal of Preventive Medicine and Public Health
• /
• 제46권2호
• /
• pp.74-81
• /
• 2013

Objectives: The objective of this study was to evaluate the performance of risk-adjusted mortality models for colorectal cancer surgery. Methods: We investigated patients (n=652) who had undergone colorectal cancer surgery (colectomy, colectomy of the rectum and sigmoid colon, total colectomy, total proctectomy) at five teaching hospitals during 2008. Mortality was defined as 30-day or in-hospital surgical mortality. Risk-adjusted mortality models were constructed using claims data (basic model) with the addition of TNM staging (TNM model), physiological data (physiological model), surgical data (surgical model), or all clinical data (composite model). Multiple logistic regression analysis was performed to develop the risk-adjustment models. To compare the performance of the models, both c-statistics using Hanley-McNeil pair-wise testing and the ratio of the observed to the expected mortality within quartiles of mortality risk were evaluated to assess the abilities of discrimination and calibration. Results: The physiological model (c=0.92), surgical model (c=0.92), and composite model (c=0.93) displayed a similar improvement in discrimination, whereas the TNM model (c=0.87) displayed little improvement over the basic model (c=0.86). The discriminatory power of the models did not differ by the Hanley-McNeil test (p>0.05). Within each quartile of mortality, the composite and surgical models displayed an expected mortality ratio close to 1. Conclusions: The addition of clinical data to claims data efficiently enhances the performance of the risk-adjusted postoperative mortality models in colorectal cancer surgery. We recommended that the performance of models should be evaluated through both discrimination and calibration.